Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM SI MGAM2	2.73e-06	5	131	3	GO:0004558
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM SI MGAM2	9.47e-06	7	131	3	GO:0090599
GeneOntologyMolecularFunction	carbohydrate binding	MGAM CALR3 MAN2A1 CALR SI GALNT12 PLA2R1 MRC2 ADGRL3 MGAM2	3.87e-05	310	131	10	GO:0030246
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	4.27e-05	2	131	2	GO:0004339
GeneOntologyMolecularFunction	microfilament motor activity	MYO1G MYH9 MYO7A MYO19	1.10e-04	38	131	4	GO:0000146
GeneOntologyMolecularFunction	glucosidase activity	MGAM SI MGAM2	1.19e-04	15	131	3	GO:0015926
GeneOntologyMolecularFunction	signaling receptor complex adaptor activity	SHANK3 PIK3R1 ROPN1B IRS2	4.34e-04	54	131	4	GO:0030159
GeneOntologyMolecularFunction	opsonin binding	CALR ITGB2 MPTX1	5.71e-04	25	131	3	GO:0001846
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	MGAM ACER1 MAN2A1 SI MGAM2	5.89e-04	103	131	5	GO:0004553
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1G KIF21B MYH9 MYO7A MYO19	1.09e-03	118	131	5	GO:0003774
GeneOntologyMolecularFunction	diacylglycerol O-acyltransferase activity	DGAT2 TMEM68	1.17e-03	8	131	2	GO:0004144
GeneOntologyMolecularFunction	2-acylglycerol O-acyltransferase activity	DGAT2 TMEM68	1.17e-03	8	131	2	GO:0003846
GeneOntologyMolecularFunction	myosin light chain binding	MYO19 MYLK2	1.17e-03	8	131	2	GO:0032027
GeneOntologyMolecularFunction	complement binding	CALR ITGB2 MPTX1	1.19e-03	32	131	3	GO:0001848
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase activator activity	PIK3R1 IRS2	1.49e-03	9	131	2	GO:0141038
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	AKAP6 ANKRD13B MYH9 WWOX ANK1 DVL3 ICE1 XPC SHANK3 DDIT3 ZZZ3 PIK3R1 ROPN1B MPHOSPH8 IRS2 CTNNB1 TRIM13	1.54e-03	1160	131	17	GO:0030674
GeneOntologyMolecularFunction	gated channel activity	GABRP GABRQ CHRNA5 CLCN5 CATSPER4 KCNG4 SCN1A KCNS3	1.64e-03	334	131	8	GO:0022836
GeneOntologyMolecularFunction	histone H4K20 methyltransferase activity	SMYD5 PRDM9	1.86e-03	10	131	2	GO:0042799
GeneOntologyMolecularFunction	complement component C1q complex binding	CALR MPTX1	1.86e-03	10	131	2	GO:0001849
GeneOntologyMolecularFunction	cAMP-dependent protein kinase inhibitor activity	PRKAR1A PRKAR1B	1.86e-03	10	131	2	GO:0004862
GeneOntologyBiologicalProcess	actin filament-based movement	AKAP6 MYO1G MYH9 MYO7A MYO19 MYLK2 SCN1A ATP1A2	5.45e-06	153	129	8	GO:0030048
GeneOntologyCellularComponent	perinuclear endoplasmic reticulum membrane	DGAT2 PIK3R1	2.35e-04	4	132	2	GO:1990578
GeneOntologyCellularComponent	plasma membrane raft	AKAP6 ITGB2 MYOF PRKAR1A CTNNB1 ATP1A2	3.45e-04	147	132	6	GO:0044853
GeneOntologyCellularComponent	anchoring junction	AKAP6 FLII DPP4 MYH9 CALR GRHL2 ITGB2 CDH22 MRC2 PIK3R1 SCN1A LRP1 CTNNB1 ATP1A2 CDH11 ADGRL3	4.42e-04	976	132	16	GO:0070161
GeneOntologyCellularComponent	membrane raft	AKAP6 DPP4 ITGB2 RFTN1 MYOF PRKAR1A CTNNB1 ATP1A2 EPHB1	4.97e-04	362	132	9	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	AKAP6 DPP4 ITGB2 RFTN1 MYOF PRKAR1A CTNNB1 ATP1A2 EPHB1	5.17e-04	364	132	9	GO:0098857
GeneOntologyCellularComponent	myosin complex	MYO1G MYH9 MYO7A MYO19	5.28e-04	59	132	4	GO:0016459
GeneOntologyCellularComponent	cortical granule	MYH9 CALR	5.84e-04	6	132	2	GO:0060473
GeneOntologyCellularComponent	glutamatergic synapse	KIF21B KALRN SPTB DVL3 SHANK3 ASAP1 MIB1 LRP1 PRKAR1A PRKAR1B CTNNB1 CDH11 ADGRL3 EPHB1	6.66e-04	817	132	14	GO:0098978
GeneOntologyCellularComponent	monoatomic ion channel complex	AKAP6 GABRP GABRQ CHRNA5 NALCN CATSPER4 KCNG4 SCN1A KCNS3	6.76e-04	378	132	9	GO:0034702
GeneOntologyCellularComponent	postsynapse	KIF21B GABRP ANK1 KALRN SPTB GABRQ SHANK3 CHRNA5 MYLK2 ASAP1 MIB1 LRP1 PRKAR1B CTNNB1 ATP1A2 ADGRL3	6.96e-04	1018	132	16	GO:0098794
GeneOntologyCellularComponent	perinuclear endoplasmic reticulum	DGAT2 PIK3R1 TRIM13	7.97e-04	29	132	3	GO:0097038
GeneOntologyCellularComponent	intercalated disc	AKAP6 SCN1A CTNNB1 ATP1A2	9.05e-04	68	132	4	GO:0014704
GeneOntologyCellularComponent	catenin complex	CDH22 CTNNB1 CDH11	1.07e-03	32	132	3	GO:0016342
GeneOntologyCellularComponent	microvillus	MYO1G WWOX MYO7A SLC7A8 CTNNB1	1.11e-03	123	132	5	GO:0005902
GeneOntologyCellularComponent	cell-cell junction	AKAP6 DPP4 MYH9 GRHL2 CDH22 PIK3R1 SCN1A CTNNB1 ATP1A2 CDH11 ADGRL3	1.33e-03	591	132	11	GO:0005911
GeneOntologyCellularComponent	spectrin-associated cytoskeleton	ANK1 SPTB	1.38e-03	9	132	2	GO:0014731
GeneOntologyCellularComponent	cAMP-dependent protein kinase complex	PRKAR1A PRKAR1B	1.72e-03	10	132	2	GO:0005952
GeneOntologyCellularComponent	transmembrane transporter complex	AKAP6 GABRP GABRQ CHRNA5 NALCN CATSPER4 KCNG4 SCN1A KCNS3 ATP1A2	1.81e-03	523	132	10	GO:1902495
Domain	Gal_mutarotase_N	MGAM SI MGAM2	1.28e-06	4	129	3	IPR031727
Domain	NtCtMGAM_N	MGAM SI MGAM2	1.28e-06	4	129	3	PF16863
Domain	Gal_mutarotase_SF_dom	MGAM MAN2A1 SI MGAM2	4.82e-06	17	129	4	IPR011013
Domain	Glyco_hydro_31_AS	MGAM SI MGAM2	6.34e-06	6	129	3	IPR030458
Domain	KRAB	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	7.17e-06	358	129	12	PF01352
Domain	KRAB	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	9.72e-06	369	129	12	SM00349
Domain	KRAB	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	9.99e-06	370	129	12	IPR001909
Domain	Glyco_hydro_31	MGAM SI MGAM2	1.10e-05	7	129	3	IPR000322
Domain	Glyco_hydro_31	MGAM SI MGAM2	1.10e-05	7	129	3	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM SI MGAM2	1.10e-05	7	129	3	PS00129
Domain	Trefoil	MGAM SI MGAM2	1.76e-05	8	129	3	PF00088
Domain	P_TREFOIL_2	MGAM SI MGAM2	2.62e-05	9	129	3	PS51448
Domain	PD	MGAM SI MGAM2	2.62e-05	9	129	3	SM00018
Domain	KRAB	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	3.90e-05	358	129	11	PS50805
Domain	Channel_four-helix_dom	NALCN CATSPER4 KCNG4 SCN1A KCNS3	4.57e-05	57	129	5	IPR027359
Domain	-	NALCN CATSPER4 KCNG4 SCN1A KCNS3	4.57e-05	57	129	5	1.20.120.350
Domain	Calreticulin	CALR3 CALR	4.73e-05	2	129	2	IPR009169
Domain	-	MGAM SI MGAM2	5.10e-05	11	129	3	4.10.110.10
Domain	Ricin_B_lectin	GALNT12 PLA2R1 MRC2 PRPF19	5.18e-05	30	129	4	IPR000772
Domain	zf-C2H2_6	ZNF311 ZNF549 ZNF621 ZNF416 PRDM9 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	6.58e-05	314	129	10	PF13912
Domain	P_trefoil_dom	MGAM SI MGAM2	6.77e-05	12	129	3	IPR000519
Domain	Myosin_head_motor_dom	MYO1G MYH9 MYO7A MYO19	1.34e-04	38	129	4	IPR001609
Domain	MYOSIN_MOTOR	MYO1G MYH9 MYO7A MYO19	1.34e-04	38	129	4	PS51456
Domain	Myosin_head	MYO1G MYH9 MYO7A MYO19	1.34e-04	38	129	4	PF00063
Domain	MYSc	MYO1G MYH9 MYO7A MYO19	1.34e-04	38	129	4	SM00242
Domain	cAMP_dep_PK_reg_su_I/II_a/b	PRKAR1A PRKAR1B ROPN1B	1.38e-04	15	129	3	IPR003117
Domain	Glyco_hydro_31_CS	MGAM SI	2.81e-04	4	129	2	IPR030459
Domain	cAMP_dep_PK_reg_su	PRKAR1A PRKAR1B	2.81e-04	4	129	2	IPR012198
Domain	Calret/calnex	CALR3 CALR	2.81e-04	4	129	2	IPR001580
Domain	CALRETICULIN_1	CALR3 CALR	2.81e-04	4	129	2	PS00803
Domain	CALRETICULIN_2	CALR3 CALR	2.81e-04	4	129	2	PS00804
Domain	Calret/calnex_CS	CALR3 CALR	2.81e-04	4	129	2	IPR018124
Domain	Calreticulin	CALR3 CALR	2.81e-04	4	129	2	PF00262
Domain	ZINC_FINGER_C2H2_1	ZNF311 FOXP2 ZNF549 TUT7 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	3.07e-04	777	129	15	PS00028
Domain	Znf_C2H2	ZNF311 FOXP2 ZNF549 TUT7 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	4.46e-04	805	129	15	IPR007087
Domain	GLYCOSYL_HYDROL_F31_2	MGAM SI	4.67e-04	5	129	2	PS00707
Domain	Calreticulin/calnexin_P_dom	CALR3 CALR	4.67e-04	5	129	2	IPR009033
Domain	RIIa	PRKAR1A PRKAR1B	6.97e-04	6	129	2	SM00394
Domain	-	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	8.49e-04	679	129	13	3.30.160.60
Domain	RICIN	GALNT12 PLA2R1 MRC2	9.29e-04	28	129	3	SM00458
Domain	RICIN_B_LECTIN	GALNT12 PLA2R1 MRC2	9.29e-04	28	129	3	PS50231
Domain	ZINC_FINGER_C2H2_2	ZNF311 FOXP2 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	9.41e-04	775	129	14	PS50157
Domain	RIIa	PRKAR1A PRKAR1B	9.72e-04	7	129	2	PF02197
Domain	K_chnl_volt-dep_Kv9	KCNG4 KCNS3	9.72e-04	7	129	2	IPR003971
Domain	zf-C2H2	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	1.02e-03	693	129	13	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	1.04e-03	694	129	13	IPR013087
Domain	Ion_trans_dom	NALCN CATSPER4 KCNG4 SCN1A KCNS3	1.17e-03	114	129	5	IPR005821
Domain	Ion_trans	NALCN CATSPER4 KCNG4 SCN1A KCNS3	1.17e-03	114	129	5	PF00520
Domain	Znf_C2H2-like	ZNF311 FOXP2 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	1.21e-03	796	129	14	IPR015880
Domain	P_TREFOIL_1	MGAM SI	1.29e-03	8	129	2	PS00025
Domain	P_trefoil_CS	MGAM SI	1.29e-03	8	129	2	IPR017957
Domain	SPEC	AKAP6 KALRN SPTB	1.38e-03	32	129	3	SM00150
Domain	Spectrin/alpha-actinin	AKAP6 KALRN SPTB	1.38e-03	32	129	3	IPR018159
Domain	ZnF_C2H2	ZNF311 FOXP2 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	1.40e-03	808	129	14	SM00355
Domain	IQ	MYH9 MYO7A MYO19 SCN1A	2.40e-03	81	129	4	SM00015
Domain	IQ_motif_EF-hand-BS	MYH9 MYO7A MYO19 SCN1A	3.51e-03	90	129	4	IPR000048
Domain	-	PLA2R1 MRC2	3.51e-03	13	129	2	2.10.10.10
Domain	Neurotransmitter_ion_chnl_CS	GABRP GABRQ CHRNA5	3.70e-03	45	129	3	IPR018000
Domain	Ank_2	ANKRD13B ANK1 SHANK3 ASAP1 MIB1 MPHOSPH8	3.82e-03	215	129	6	PF12796
Domain	SH3	KALRN MYO7A SHANK3 ASAP1 ARHGAP4 PIK3R1	3.91e-03	216	129	6	SM00326
Domain	SH3	KALRN MYO7A SHANK3 ASAP1 ARHGAP4 PIK3R1	3.91e-03	216	129	6	PS50002
Domain	Neur_chan_memb	GABRP GABRQ CHRNA5	3.93e-03	46	129	3	PF02932
Domain	IQ	MYH9 MYO7A MYO19 SCN1A	3.95e-03	93	129	4	PS50096
Domain	FN_type2_col-bd	PLA2R1 MRC2	4.08e-03	14	129	2	IPR000562
Domain	FN2_2	PLA2R1 MRC2	4.08e-03	14	129	2	PS51092
Domain	FN2_1	PLA2R1 MRC2	4.08e-03	14	129	2	PS00023
Domain	fn2	PLA2R1 MRC2	4.08e-03	14	129	2	PF00040
Domain	FN2	PLA2R1 MRC2	4.08e-03	14	129	2	SM00059
Domain	Neurotrans-gated_channel_TM	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	IPR006029
Domain	-	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	2.70.170.10
Domain	ER_TARGET	CALR3 CALR PDIA5	4.18e-03	47	129	3	PS00014
Domain	Neur_chan_LBD	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	PS00236
Domain	Neur_channel	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	IPR006201
Domain	Neur_chan_lig-bd	GABRP GABRQ CHRNA5	4.18e-03	47	129	3	IPR006202
Domain	SH3_domain	KALRN MYO7A SHANK3 ASAP1 ARHGAP4 PIK3R1	4.27e-03	220	129	6	IPR001452
Domain	cNMP-bd_CS	PRKAR1A PRKAR1B	5.33e-03	16	129	2	IPR018488
Domain	Glycoside_hydrolase_SF	MGAM SI MGAM2	5.86e-03	53	129	3	IPR017853
Domain	BTB_2	KCNG4 KCNS3 TRIM13	5.86e-03	53	129	3	PF02214
Domain	T1-type_BTB	KCNG4 KCNS3 TRIM13	5.86e-03	53	129	3	IPR003131
Domain	ZF_ZZ_2	ZZZ3 MIB1	6.74e-03	18	129	2	PS50135
Domain	ZF_ZZ_1	ZZZ3 MIB1	6.74e-03	18	129	2	PS01357
Domain	ZZ	ZZZ3 MIB1	6.74e-03	18	129	2	PF00569
Pubmed	Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.	CPNE2 RELN ANK1 ASAP1 KCNG4 SCN1A ROBO1 KCNS3 ATP1A2 CDH11	1.88e-06	376	132	10	24154525
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MYH9 MAN2A1 CALR TUT7 CHRNA5 PLA2R1 MYOF MRC2 LRP1 PDIA5 ROBO1 PRPF19 CTNNB1 TRIM13 ADGRA3 PCYOX1 CA5A	3.23e-06	1201	132	17	35696571
Pubmed	Impaired Interneuron Development after Foxg1 Disruption.	RELN FOXP2 ROBO1 EPHB1	4.37e-06	29	132	4	26620267
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYH9 WWOX DVL3 TTC27 ICE1 BIRC6 ZZZ3 ZNF644 LRP1 IRS2	4.79e-06	418	132	10	34709266
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH9 PDE3B ANK1 MYO7A MYO19 INTS1 ICE1 BIRC6 FREM2 ZZZ3 DQX1 KCNG4 CA5A	4.92e-06	736	132	13	29676528
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	PCDH20 FREM2 MIB1 CTNNB1 ADGRA3	5.84e-06	67	132	5	21875946
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF311 ZNF644 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	6.27e-06	181	132	7	37372979
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	ANK1 MYO7A FREM2 PRDM9 HPS1	8.33e-06	72	132	5	25917818
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYH9 FOXP2 MYO7A ASAP1 MIB1 ROBO1 PRPF19 IRS2 CTNNB1	9.80e-06	358	132	9	32460013
Pubmed	Cadherin-11 is expressed in invasive breast cancer cell lines.	CTNNB1 CDH11	1.43e-05	2	132	2	10029089
Pubmed	Inactivating frameshift mutation of putative tumor suppressor genes PLA2R1 and SRPK1 in gastric and colorectal cancers.	SRPK1 PLA2R1	1.43e-05	2	132	2	28212809
Pubmed	Promoter for the regulatory type I beta subunit of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase directs transgene expression in the central nervous system.	PRKAR1A PRKAR1B	1.43e-05	2	132	2	1448119
Pubmed	Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.	DPP4 IRS2	1.43e-05	2	132	2	22315446
Pubmed	Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis.	ANK1 SPTB	1.43e-05	2	132	2	26830532
Pubmed	Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility.	KALRN EPHB1	1.43e-05	2	132	2	21041834
Pubmed	Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.	PIK3R1 IRS2	1.43e-05	2	132	2	11438664
Pubmed	Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP.	DDIT3 TRIM13	1.43e-05	2	132	2	31901873
Pubmed	H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes.	PIK3R1 CTNNB1	1.43e-05	2	132	2	10477752
Pubmed	The p85 subunit of phosphoinositide 3-kinase is associated with beta-catenin in the cadherin-based adhesion complex.	PIK3R1 CTNNB1	1.43e-05	2	132	2	11716761
Pubmed	Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.	PIK3R1 IRS2	1.43e-05	2	132	2	23617393
Pubmed	β-catenin regulates FOXP2 transcriptional activity via multiple binding sites.	FOXP2 CTNNB1	1.43e-05	2	132	2	33284517
Pubmed	Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.	PRKAR1A CTNNB1	1.43e-05	2	132	2	18647815
Pubmed	Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues.	ANK1 SPTB	1.43e-05	2	132	2	11427698
Pubmed	The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin.	CALR LRP1	1.43e-05	2	132	2	17947714
Pubmed	PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.	PIK3R1 EPHB1	1.43e-05	2	132	2	22879882
Pubmed	Calreticulin-2 is localized in the lumen of the endoplasmic reticulum but is not a Ca2+ -binding protein.	CALR3 CALR	1.43e-05	2	132	2	21590275
Pubmed	Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex.	PRKAR1A CTNNB1	1.43e-05	2	132	2	31208233
Pubmed	β-Catenin regulates membrane potential in muscle cells by regulating the α2 subunit of Na,K-ATPase.	CTNNB1 ATP1A2	1.43e-05	2	132	2	24674304
Pubmed	Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human small intestine and colon.	DPP4 SI	1.43e-05	2	132	2	1677636
Pubmed	Expression of DGAT2 in white adipose tissue is regulated by central leptin action.	DGAT2 IRS2	1.43e-05	2	132	2	15550388
Pubmed	RNF128 suppresses the malignancy of colorectal cancer cells via inhibition of Wnt/β-catenin signaling.	CTNNB1 RNF128	1.43e-05	2	132	2	35035697
Pubmed	Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit.	ANK1 SPTB	1.43e-05	2	132	2	8159688
Pubmed	Interaction between the α-glucosidases, sucrase-isomaltase and maltase-glucoamylase, in human intestinal brush border membranes and its potential impact on disaccharide digestion.	MGAM SI	1.43e-05	2	132	2	36968271
Pubmed	LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion.	ITGB2 LRP1	1.43e-05	2	132	2	15328156
Pubmed	[Clinical characteristics and genetic analysis of hereditary spherocytosis caused by mutations of ANK1 and SPTB genes].	ANK1 SPTB	1.43e-05	2	132	2	31014431
Pubmed	Contribution of the Individual Small Intestinal α-Glucosidases to Digestion of Unusual α-Linked Glycemic Disaccharides.	MGAM SI	1.43e-05	2	132	2	27480812
Pubmed	Identification of a novel calreticulin isoform (Crt2) in human and mouse.	CALR3 CALR	1.43e-05	2	132	2	12384296
Pubmed	FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression.	FNDC3B MYH9	1.43e-05	2	132	2	32232887
Pubmed	Structural basis for substrate selectivity in human maltase-glucoamylase and sucrase-isomaltase N-terminal domains.	MGAM SI	1.43e-05	2	132	2	20356844
Pubmed	Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.	PIK3R1 CTNNB1	1.43e-05	2	132	2	15817165
Pubmed	Structural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrin.	ANK1 SPTB	1.43e-05	2	132	2	17520478
Pubmed	Expression of LRP1 and CHOP genes associated with peripheral neuropathy in type 2 diabetes mellitus: Correlations with nerve conduction studies.	DDIT3 LRP1	1.43e-05	2	132	2	30902789
Pubmed	Protein kinase A activation enhances β-catenin transcriptional activity through nuclear localization to PML bodies.	PRKAR1A CTNNB1	1.43e-05	2	132	2	25299576
Pubmed	Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes.	PRKAR1A PRKAR1B	1.43e-05	2	132	2	8407966
Pubmed	Unconventional myosin VIIA is a novel A-kinase-anchoring protein.	MYO7A PRKAR1A	1.43e-05	2	132	2	10889203
Pubmed	Genetics of migraine: an update with special attention to genetic comorbidity.	SCN1A ATP1A2	1.43e-05	2	132	2	18451712
Pubmed	The hyh mutation uncovers roles for alpha Snap in apical protein localization and control of neural cell fate.	RELN FOXP2 CTNNB1	2.89e-05	16	132	3	14758363
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 FLII RELN KALRN TTLL5 SPTB ZNF189 DVL3 TTC27 XPC PIK3R1 MIB1 LRP1 PRKAR1A ROBO1 ATP1A2	3.09e-05	1285	132	16	35914814
Pubmed	Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells.	CALR CTNNB1	4.28e-05	3	132	2	19100874
Pubmed	Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine.	SCN1A ATP1A2	4.28e-05	3	132	2	18056581
Pubmed	Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling.	PIK3R1 IRS2	4.28e-05	3	132	2	8910607
Pubmed	Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly.	CALR LRP1	4.28e-05	3	132	2	12821648
Pubmed	Partial characterization of murine intestinal maltase-glucoamylase.	MGAM SI	4.28e-05	3	132	2	12150962
Pubmed	Dishevelled-KSRP complex regulates Wnt signaling through post-transcriptional stabilization of beta-catenin mRNA.	DVL3 CTNNB1	4.28e-05	3	132	2	20332102
Pubmed	TRPV4 mediates the Ca2+ influx required for the interaction between flightless-1 and non-muscle myosin, and collagen remodeling.	FLII MYH9	4.28e-05	3	132	2	28526784
Pubmed	Language development and disorders: Possible genes and environment interactions.	FOXP2 ROBO1	4.28e-05	3	132	2	30077386
Pubmed	Familial Hemiplegic Migraine	SCN1A ATP1A2	4.28e-05	3	132	2	20301562
Pubmed	Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.	MYH9 CTNNB1	4.28e-05	3	132	2	32296025
Pubmed	Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma.	DPP4 NRF1	4.28e-05	3	132	2	36071454
Pubmed	Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells.	CTNNB1 CDH11	4.28e-05	3	132	2	19274078
Pubmed	Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.	DPP4 SI	4.28e-05	3	132	2	20841351
Pubmed	The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families.	SCN1A ATP1A2	4.28e-05	3	132	2	29486580
Pubmed	Expression of beta-catenin in developing auditory epithelia of mice.	MYO7A CTNNB1	4.28e-05	3	132	2	15078071
Pubmed	The Neuronal Migration Factor srGAP2 Achieves Specificity in Ligand Binding through a Two-Component Molecular Mechanism.	ARHGAP4 ROBO1	4.28e-05	3	132	2	26365803
Pubmed	Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.	PIK3R1 IRS2	4.28e-05	3	132	2	15380067
Pubmed	Exclusion of catalytic and regulatory subunits of cAMP-dependent protein kinase as candidate genes for the defect causing cystic fibrosis.	PRKAR1A PRKAR1B	4.28e-05	3	132	2	3479018
Pubmed	Cadherin 22 participates in the self-renewal of mouse female germ line stem cells via interaction with JAK2 and β-catenin.	CDH22 CTNNB1	4.28e-05	3	132	2	29063123
Pubmed	Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1.	PIK3R1 IRS2	4.28e-05	3	132	2	7534300
Pubmed	Hematopoietic stem/progenitor cells directly contribute to arteriosclerotic progression via integrin β2.	ITGB2 LRP1	4.28e-05	3	132	2	25546260
Pubmed	Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells.	ANK1 SPTB	4.28e-05	3	132	2	15929114
Pubmed	The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.	CTNNB1 CDH11	4.28e-05	3	132	2	22139084
Pubmed	Changing patterns in cytoskeletal mRNA expression and protein synthesis during murine erythropoiesis in vivo.	ANK1 SPTB	4.28e-05	3	132	2	1385865
Pubmed	Inherited hemolytic disease in mice: a review and update.	ANK1 SPTB	4.28e-05	3	132	2	6763106
Pubmed	Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.	ITGB2 LRP1	4.28e-05	3	132	2	21676865
Pubmed	Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.	CALR LRP1	4.28e-05	3	132	2	18653767
Pubmed	Mapping the binding sites of human erythrocyte ankyrin for the anion exchanger and spectrin.	ANK1 SPTB	4.28e-05	3	132	2	2141335
Pubmed	A clinical and experimental study of adult hereditary spherocytosis in the Chinese population.	ANK1 SPTB	4.28e-05	3	132	2	32133777
Pubmed	A kinase anchoring protein (AKAP) interaction and dimerization of the RIalpha and RIbeta regulatory subunits of protein kinase a in vivo by the yeast two hybrid system.	PRKAR1A PRKAR1B	4.28e-05	3	132	2	12634056
Pubmed	Higher burden of rare frameshift indels in genes related to synaptic transmission separate familial hemiplegic migraine from common types of migraine.	SCN1A ATP1A2	4.28e-05	3	132	2	31980564
Pubmed	Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver.	RGN CTNNB1	4.28e-05	3	132	2	19690176
Pubmed	Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.	MYH9 CTNNB1	4.28e-05	3	132	2	32685004
Pubmed	PAI-1 modulates cell migration in a LRP1-dependent manner via β-catenin and ERK1/2.	LRP1 CTNNB1	4.28e-05	3	132	2	25694133
Pubmed	Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation.	PIK3R1 IRS2	4.28e-05	3	132	2	9334184
Pubmed	Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.	PIK3R1 IRS2	4.28e-05	3	132	2	15821749
Pubmed	Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain.	RELN FOXP2	4.28e-05	3	132	2	12687690
Pubmed	Alveolar progenitor differentiation and lactation depends on paracrine inhibition of notch via ROBO1/CTNNB1/JAG1.	ROBO1 CTNNB1	4.28e-05	3	132	2	34758082
Pubmed	PI3K-Akt inactivation induced CHOP expression in endoplasmic reticulum-stressed cells.	DDIT3 PIK3R1	4.28e-05	3	132	2	16375864
Pubmed	SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.	WWOX CTNNB1	4.28e-05	3	132	2	24969559
Pubmed	FHM3 in familial hemiplegic migraine is more resistant to mutation than FHM1 and FHM2.	SCN1A ATP1A2	4.28e-05	3	132	2	19007941
Pubmed	The expression and significance of WWOX and β-catenin in hepatocellular carcinoma.	WWOX CTNNB1	4.28e-05	3	132	2	23030478
Pubmed	The histone H3-lysine 4-methyltransferase Mll4 regulates the development of growth hormone-releasing hormone-producing neurons in the mouse hypothalamus.	FOXP2 NRF1 PIK3R1	5.81e-05	20	132	3	33431871
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	DPP4 MAN2A1 ITGB2 FREM2 PLXDC2 LRP1 PCYOX1	5.96e-05	257	132	7	16335952
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	MGAM MYH9 ANK1 MYOF MIB1 CTNNB1	7.17e-05	182	132	6	31067453
Pubmed	CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma.	KIF21B FLII MYH9 WWOX MYOF SCN1A PRKAR1A PRPF19 HSP90AB2P	7.89e-05	468	132	9	36042349
Pubmed	Structural abnormalities develop in the brain after ablation of the gene encoding nonmuscle myosin II-B heavy chain.	MYH9 CTNNB1	8.54e-05	4	132	2	11283949
Pubmed	PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells.	PIK3R1 CTNNB1	8.54e-05	4	132	2	23583404
Pubmed	4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.	PIK3R1 CTNNB1	8.54e-05	4	132	2	23874982
Pubmed	Cyclic nucleotide mapping of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.	PRKAR1A PRKAR1B	8.54e-05	4	132	2	24605759
Pubmed	The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes.	ANK1 SPTB	8.54e-05	4	132	2	379653
Pubmed	Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.	WWOX DVL3	8.54e-05	4	132	2	19465938
Cytoband	19q13.43	ZNF549 ZNF324 ZNF749 ZNF324B ZNF543	5.57e-06	87	132	5	19q13.43
Cytoband	Ensembl 112 genes in cytogenetic band chr2p13	SMYD5 DQX1 DGUOK PCYOX1	7.40e-04	140	132	4	chr2p13
Cytoband	2q24.3	DPP4 SCN1A	9.59e-04	16	132	2	2q24.3
Cytoband	2p22.3	TTC27 BIRC6	1.36e-03	19	132	2	2p22.3
Cytoband	3q21.2	KALRN ROPN1B	1.66e-03	21	132	2	3q21.2
Cytoband	11q13.5	MYO7A DGAT2	1.66e-03	21	132	2	11q13.5
Cytoband	8q12.1	XKR4 TMEM68	3.17e-03	29	132	2	8q12.1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF311 ZNF549 ZNF189 ZNF621 ZNF416 ZNF786 PRDM9 ZNF620 ZNF324 ZNF749 ZNF324B ZNF543	4.99e-04	718	98	12	28
GeneFamily	Myb/SANT domain containing\|NineTeen complex	PRPF19 CTNNB1	6.00e-04	7	98	2	1361
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	PDE3B FOXP2 COL6A6 CARMIL1 PLXDC2 MRC2 LRP1 NAV2 PODN ROBO1	2.43e-10	187	132	10	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FNDC3B PDE3B WWOX FOXP2 CARMIL1 RFTN1 PLXDC2 MRC2 ROBO1 ADGRL3	3.66e-10	195	132	10	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 PLA2R1 NALCN MRC2 LRP1 NAV2 ROBO1 CDH11	6.00e-09	191	132	9	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 PLA2R1 NALCN MRC2 LRP1 NAV2 ROBO1 CDH11	6.00e-09	191	132	9	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	FNDC3B PDE3B FOXP2 CARMIL1 PLXDC2 MRC2 PODN ROBO1 IRS2	6.87e-09	194	132	9	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	PDE3B WWOX FOXP2 CARMIL1 PLXDC2 MRC2 LRP1 NAV2 ROBO1	6.87e-09	194	132	9	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PDE3B FOXP2 CARMIL1 PLXDC2 MRC2 LRP1 NAV2 PODN ROBO1	7.19e-09	195	132	9	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 PLXDC2 MRC2 LRP1 KCNS3 IRS2 ATP1A2 CDH11	7.38e-08	182	132	8	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 PLXDC2 MRC2 LRP1 KCNS3 IRS2 ATP1A2 CDH11	7.38e-08	182	132	8	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ANK1 KALRN FREM2 ROBO1 CSMD1 ADGRL3	8.03e-08	184	132	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ANK1 KALRN FREM2 ROBO1 CSMD1 ADGRL3	8.03e-08	184	132	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ANK1 KALRN FREM2 ROBO1 CSMD1 ADGRL3	8.03e-08	184	132	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LA\|World / Chamber and Cluster_Paper	FOXP2 CARMIL1 PLXDC2 MRC2 LRP1 NAV2 PODN ROBO1	1.16e-07	193	132	8	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	FNDC3B PDE3B FOXP2 CARMIL1 PLXDC2 MRC2 ROBO1 ADGRL3	1.21e-07	194	132	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	FNDC3B FOXP2 CARMIL1 MRC2 LRP1 PODN ROBO1 ADGRL3	1.25e-07	195	132	8	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	PDE3B FOXP2 CARMIL1 PLXDC2 MRC2 LRP1 NAV2 ROBO1	1.25e-07	195	132	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A6 PLXDC2 MRC2 LRP1 NAV2 PODN KCNS3 CDH11	1.36e-07	197	132	8	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A6 PLXDC2 MRC2 LRP1 NAV2 PODN ROBO1 CDH11	1.41e-07	198	132	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ASAP1 RFTN1 MYOF MRC2 NAV2 ROBO1 CDH11	1.41e-07	198	132	8	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL6A6 PLA2R1 PLXDC2 MRC2 NAV2 PODN ROBO1 CDH11	1.41e-07	198	132	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3B RGN PLXDC2 MRC2 LRP1 NAV2 PODN CDH11	1.52e-07	200	132	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPNE2 ANK1 TTLL5 GALNT12 SHANK3 SLC46A3 GPATCH3	6.30e-07	165	132	7	c39f0479955c4e23921f7a450d3bc251a002200f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NALCN PIK3R1 NAV2 PODN ROBO1 ATP1A2 CDH11	9.35e-07	175	132	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 PLA2R1 NALCN LRP1 NAV2 PODN CDH11	1.31e-06	184	132	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH20 MRC2 LRP1 PODN ROBO1 ATP1A2 CDH11	1.31e-06	184	132	7	3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPP4 RELN KALRN SHANK3 NALCN PRKAR1B EPHB1	1.36e-06	185	132	7	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC2 SCN1A LRP1 PODN ATP1A2 CSMD1 CDH11	1.41e-06	186	132	7	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	facs-Heart-Unknown-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 CALR3 ANK1 SPTB DGAT2 APOBEC2 RNF128	1.46e-06	187	132	7	0ffb988e0da2c7205c3515eca8e9851739bff5c5
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 CALR3 ANK1 SPTB DGAT2 APOBEC2 RNF128	1.51e-06	188	132	7	4db566f3f708e66730aa9e16f4d73d91dc534177
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 CALR3 ANK1 SPTB DGAT2 APOBEC2 RNF128	1.51e-06	188	132	7	6704b92991ad8c0a910e9f36cd33d00bd26dcb8f
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	PDE3B COL6A6 RGN PLXDC2 PIK3R1 KCNS3 CDH11	1.62e-06	190	132	7	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLA2R1 PLXDC2 MRC2 LRP1 KCNS3 ATP1A2 CDH11	1.68e-06	191	132	7	80484d39f34703a33b9bac09826b7a526e883cab
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLA2R1 PLXDC2 MRC2 LRP1 KCNS3 ATP1A2 CDH11	1.68e-06	191	132	7	5c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FNDC3B PDE3B FOXP2 CARMIL1 PLXDC2 ROBO1 ADGRL3	1.68e-06	191	132	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FNDC3B FOXP2 CARMIL1 RFTN1 MRC2 ROBO1 ADGRL3	1.68e-06	191	132	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 MRC2 LRP1 NAV2 PODN ROBO1 CDH11	1.74e-06	192	132	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 KALRN CARMIL1 MYLK2 ATP1A2 CSMD1 ADGRL3	1.74e-06	192	132	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKAP6 KALRN CARMIL1 MYLK2 ATP1A2 CSMD1 ADGRL3	1.74e-06	192	132	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A6 MYOF PLXDC2 MRC2 LRP1 ROBO1 CDH11	1.74e-06	192	132	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	(07)_Brush\|World / shred by cell type and Timepoint	ANK1 SPTB PCDH20 ARHGAP4 KCNS3 ATP1A2 ADGRL3	1.80e-06	193	132	7	9af9d22a130ff97a9c37142a65e841b056d08640
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NALCN MRC2 LRP1 NAV2 PODN CDH11 ADGRL3	1.86e-06	194	132	7	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A6 MYOF PLXDC2 MRC2 LRP1 ROBO1 CDH11	1.86e-06	194	132	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 NAV2 CDH11	1.86e-06	194	132	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A6 MYOF PLXDC2 MRC2 LRP1 ROBO1 CDH11	1.86e-06	194	132	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 CDH11 ADGRL3	1.92e-06	195	132	7	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 CDH11 ADGRL3	1.92e-06	195	132	7	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 CDH11 ADGRL3	1.92e-06	195	132	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NALCN MRC2 LRP1 NAV2 PODN CDH11	1.92e-06	195	132	7	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 PLA2R1 NALCN ATP1A2 CDH11 ADGRL3	1.99e-06	196	132	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 CDH11 ADGRL3	1.99e-06	196	132	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 NALCN MRC2 LRP1 CDH11 ADGRL3	1.99e-06	196	132	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A6 KALRN CARMIL1 PLXDC2 LRP1 ROBO1 CDH11	1.99e-06	196	132	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 PLA2R1 NALCN ATP1A2 CDH11 ADGRL3	1.99e-06	196	132	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ASAP1 MYOF MRC2 NAV2 ROBO1 CDH11	2.06e-06	197	132	7	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP MYH9 CARMIL1 GALNT12 PCDH20 PLA2R1 MYOF	2.20e-06	199	132	7	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A6 MYOF PLXDC2 MRC2 LRP1 ROBO1 CDH11	2.20e-06	199	132	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GABRP MYH9 CARMIL1 GALNT12 PLA2R1 MYOF PIK3R1	2.20e-06	199	132	7	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A6 MYOF PLXDC2 MRC2 LRP1 ROBO1 CDH11	2.28e-06	200	132	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A6 MYO7A PLXDC2 MRC2 LRP1 ROBO1 CDH11	2.28e-06	200	132	7	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A6 PLXDC2 LRP1 NAV2 PODN ROBO1 CDH11	2.28e-06	200	132	7	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3B COL6A6 RGN MRC2 LRP1 PODN CDH11	2.28e-06	200	132	7	8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A6 PLXDC2 LRP1 NAV2 PODN ROBO1 CDH11	2.28e-06	200	132	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A6 PLXDC2 MRC2 LRP1 NAV2 PODN CDH11	2.28e-06	200	132	7	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A6 MYO7A PLXDC2 MRC2 LRP1 ROBO1 CDH11	2.28e-06	200	132	7	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ASAP1 RFTN1 MRC2 NAV2 ROBO1 CDH11	6.95e-06	155	132	6	82e602f31981c6b48abff2a04b2ab5d26d4462a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ASAP1 RFTN1 MRC2 NAV2 ROBO1 CDH11	6.95e-06	155	132	6	979c1d53b435a82c57d16707eed8ba7346326866
ToppCell	droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 ANK1 TTLL5 GALNT12 SLC46A3 GPATCH3	9.59e-06	164	132	6	78de403446fe0eb375c82ff1832cc5fbb8e20afa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN RFTN1 PLA2R1 NALCN ROBO1 CDH11	1.10e-05	168	132	6	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WWOX ANK1 ZNF416 RFTN1 PIK3R1 CAMKMT	1.30e-05	173	132	6	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G KIF21B ITGB2 ZNF786 ARHGAP4 CD37	1.30e-05	173	132	6	2cba41c3d9d3076f703115d19729073a3ac3feb6
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G KIF21B ITGB2 ZNF786 ARHGAP4 CD37	1.30e-05	173	132	6	11d69a4ab4a87b8820cd3bd204de8c4124450a90
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	RELN KALRN SHANK3 ASAP1 CDH22 EPHB1	1.43e-05	176	132	6	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	RELN KALRN SHANK3 ASAP1 CDH22 EPHB1	1.43e-05	176	132	6	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-T_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXP2 DVL3 GALNT12 SMYD5 ARHGAP4 RNF128	1.48e-05	177	132	6	baf78a8dad55f124f56585f88b10b58c0269680f
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	PDE3B FOXP2 COL6A6 PLXDC2 MRC2 ROBO1	1.58e-05	179	132	6	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	HSPCs-Neutro_prog.\|HSPCs / Lineage and Cell class	MGAM CALR XPC DGAT2 CD37 PDIA5	1.63e-05	180	132	6	328192f4678dcdc01c806362b225e770d23498d6
ToppCell	NS-moderate-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MYO1G KIF21B ZNF311 PDE3B CD37 MSS51	1.68e-05	181	132	6	7fb3c1d29c542a3cea7fa654432d501d82df138f
ToppCell	Bronchial_Biopsy-Immune-T_and_NK\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	MYO1G KIF21B DPP4 MYO7A ITGB2 RFTN1	1.73e-05	182	132	6	dab2ea0298e26649a923c34d4699e437e9385b90
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLA2R1 PLXDC2 MRC2 LRP1 KCNS3 CDH11	1.84e-05	184	132	6	924400f47e6b2cdf7b0d538df75857935cf0209b
ToppCell	droplet-Kidney-nan-21m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH20 MRC2 LRP1 ROBO1 ATP1A2 CDH11	1.90e-05	185	132	6	33cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FNDC3B DPP4 RELN WWOX LRP1 CA5A	1.90e-05	185	132	6	1d874608aa2062024323512f68889219471b2f00
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH20 MRC2 LRP1 ROBO1 ATP1A2 CDH11	1.90e-05	185	132	6	9954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH20 MRC2 SCN1A LRP1 ATP1A2 CDH11	1.90e-05	185	132	6	785c55d39909fac74415f24427979691e7e694e6
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH20 MRC2 SCN1A LRP1 ATP1A2 CDH11	1.90e-05	185	132	6	97a1dcacbc48dc3f41c26fbb59af35c935f894d4
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ANK1 SPTB CDH22 DGAT2 RNF128	1.96e-05	186	132	6	337f768cc43db2db96ba6495b076006b1a5b0331
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ANK1 SPTB CDH22 DGAT2 RNF128	1.96e-05	186	132	6	e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCell	Tuft\|World / Class top	ANK1 SPTB PCDH20 NAV2 KCNS3 ATP1A2	1.96e-05	186	132	6	f4d83f15ab7b49c0920a322cd832413ece7c9948
ToppCell	Tuft-tuft-2\|World / Class top	ANK1 SPTB PCDH20 NAV2 KCNS3 ATP1A2	2.02e-05	187	132	6	4ec6eee866619dfe13c84f5d2e812bb380d37139
ToppCell	facs-Heart-Unknown\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ANK1 SPTB DGAT2 APOBEC2 RNF128	2.02e-05	187	132	6	362e56426a568423a81e8a30e3ecf99b76135843
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	RGN NALCN PLXDC2 PODN ROBO1 CDH11	2.02e-05	187	132	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	facs-Heart-Unknown-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 ANK1 SPTB DGAT2 APOBEC2 RNF128	2.02e-05	187	132	6	c004567767b89f3d89f5c7b28d952f3445957e1e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FOXP2 MRC2 PIK3R1 LRP1 PODN CDH11	2.08e-05	188	132	6	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 NALCN MRC2 LRP1 CSMD1 CDH11	2.14e-05	189	132	6	544d95df910f1b276995624509a7e41b219baca0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NALCN MRC2 NAV2 ROBO1 CDH11	2.14e-05	189	132	6	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RELN KALRN SHANK3 MYLK2 NALCN EPHB1	2.14e-05	189	132	6	0d18ea72bd58d32a8ab9a61cf97f5786642f804b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NALCN MRC2 NAV2 ROBO1 CDH11	2.14e-05	189	132	6	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	AKAP6 MYH9 KALRN CARMIL1 MYOF ADGRL3	2.14e-05	189	132	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC2 PIK3R1 LRP1 NAV2 ROBO1 CDH11	2.14e-05	189	132	6	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN KALRN SHANK3 ASAP1 CDH22 EPHB1	2.21e-05	190	132	6	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ASAP1 MRC2 NAV2 ROBO1 CDH11	2.21e-05	190	132	6	1121eb607a984c59fbffe7220837fc178745aa55
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	FLII PDE3B DVL3 DDIT3 BORCS8 CLCN5 MRC2 ZNF324 IRS2 FH	2.51e-07	200	131	10	4841_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	FLII MYO7A TTLL5 SLC7A8 BORCS8 MYOF MPHOSPH8 KDM4B	1.70e-05	194	131	8	2221_DN
Drug	Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A	GABRP RELN WWOX RFTN1 MYOF APOBEC2 NAV2 IRS2	1.83e-05	196	131	8	3579_UP
Drug	nifedipine; Down 200; 10uM; MCF7; HG-U133A	INTS1 DVL3 SLC7A8 CDH22 SLC46A3 CLCN5 HERC3 KDM4B	1.90e-05	197	131	8	335_DN
Drug	DAPH; Up 200; 10uM; MCF7; HG-U133A	DVL3 DDIT3 BORCS8 MRC2 HPS1 PEX5 PRKAR1B ZNF324B	1.90e-05	197	131	8	624_UP
Drug	AC1L1GEZ	DPP4 CALR SPTB GABRQ ITGB2 HPS1 CDH11 CA5A	2.12e-05	200	131	8	CID000003653
Drug	rhodoquinone	WWOX CALR BIRC6	2.17e-05	10	131	3	CID006441300
Drug	NSC-210825	MGAM CALR	3.29e-05	2	131	2	CID000427282
Drug	Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	FNDC3B MYO7A DDIT3 SLC7A8 MYOF MRC2 IRS2	3.99e-05	160	131	7	2896_UP
Drug	Ro 11-3128	GABRP CALR GABRQ	5.10e-05	13	131	3	CID000093364
Drug	FGIN-1-27	GABRP WWOX GABRQ DDIT3	5.35e-05	36	131	4	CID000132496
Drug	premazepam	GABRP CALR GABRQ	8.05e-05	15	131	3	CID000072104
Drug	Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A	MYO7A DDIT3 SLC7A8 NAV2 IRS2 ADGRL3 EPHB1	8.12e-05	179	131	7	4721_UP
Drug	brinzolamide	GABRP GABRQ ARHGAP4 CA5A	8.15e-05	40	131	4	CID000068844
Drug	ethanol	FLII MGAM ANK1 SPTB GABRQ BIRC6 ITGB2 MYLK2 ARHGAP4 PIK3R1 PRKAR1A IRS2 FH PCYOX1 CA5A	9.67e-05	837	131	15	CID000000702
Drug	Copper silicide	MGAM SI	9.82e-05	3	131	2	CID006336988
Drug	discretamine	WWOX CALR	9.82e-05	3	131	2	CID000022955
Drug	AC1L4WHE	MGAM WWOX	9.82e-05	3	131	2	CID000193533
Drug	hydroxylamine sulfate	MGAM CALR	9.82e-05	3	131	2	CID000024846
Drug	Ro 19-4603	GABRP CALR GABRQ	9.87e-05	16	131	3	CID000127382
Drug	PK11195	GABRP CALR GABRQ DDIT3	9.89e-05	42	131	4	CID000001345
Drug	0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A	CHRNA5 ASAP1 SLC7A8 SLC46A3 PIK3R1 HPS1 ZNF324B	1.14e-04	189	131	7	3690_DN
Drug	Org 9935	PDE3B CALR ITGB2	1.19e-04	17	131	3	CID000131100
Drug	CL 218,872	GABRP CALR GABRQ	1.19e-04	17	131	3	CID000107950
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF21B DDIT3 SLC7A8 HPS1 NAV2 IRS2 KDM4B	1.22e-04	191	131	7	5344_UP
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	DDIT3 MYOF PIK3R1 APOBEC2 HPS1 NAV2 ALDH4A1	1.26e-04	192	131	7	3470_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	GABRP CALR TTLL5 LRP1 PRKAR1B CAMKMT ALDH4A1	1.30e-04	193	131	7	4240_DN
Drug	Niacin [59-67-6]; Up 200; 32.4uM; HL60; HT_HG-U133A	DPP4 ANK1 KALRN MYO7A GABRQ BORCS8 ALDH4A1	1.34e-04	194	131	7	3043_UP
Drug	Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A	KALRN TTLL5 DDIT3 MYOF HPS1 NAV2 IRS2	1.34e-04	194	131	7	5355_UP
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	TTLL5 DVL3 ITGB2 MYOF LRP1 ALDH4A1 IRS2	1.38e-04	195	131	7	4597_DN
Drug	lormetazepam	GABRP CALR GABRQ	1.43e-04	18	131	3	CID000013314
Drug	phenazepam	GABRP CALR GABRQ	1.43e-04	18	131	3	CID000040113
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PDE3B NRF1 GALNT12 MYOF CLCN5 ZNF324 IRS2	1.43e-04	196	131	7	7330_UP
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	PDE3B BORCS8 SLC46A3 GPATCH3 MRC2 PEX5 ZNF324	1.43e-04	196	131	7	2751_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	TTLL5 DVL3 GALNT12 SLC7A8 ARHGAP4 ROBO1 IRS2	1.43e-04	196	131	7	1536_UP
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PDE3B NRF1 MYO7A SLC7A8 ARHGAP4 PRKAR1B ZNF324	1.47e-04	197	131	7	2233_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; PC3; HT_HG-U133A	ANK1 TTLL5 SPTB GABRQ PRDM9 CLCN5 KDM4B	1.47e-04	197	131	7	5083_UP
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	CARMIL1 MYOF HPS1 PEX5 PRKAR1B ALDH4A1 KDM4B	1.47e-04	197	131	7	3532_DN
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	RELN KALRN TTLL5 RFTN1 APOBEC2 HPS1 IRS2	1.47e-04	197	131	7	5274_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; HL60; HT_HG-U133A	FLII PDE3B WWOX CD37 HPS1 PRKAR1A PCYOX1	1.47e-04	197	131	7	2363_DN
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	KALRN SLC7A8 ARHGAP4 MRC2 ZNF749 ATP1A2 CDH11	1.47e-04	197	131	7	3978_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; ssMCF7; HG-U133A	NRF1 MYO19 SLC7A8 CLCN5 HPS1 IRS2 KDM4B	1.47e-04	197	131	7	497_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A	PDE3B DDIT3 RFTN1 HPS1 ZNF324 ZNF749 IRS2	1.47e-04	197	131	7	7239_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A	DPP4 CALR DDIT3 SDHAF3 PIK3R1 HPS1 ALDH4A1	1.47e-04	197	131	7	1223_UP
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	WWOX CALR GALNT12 BORCS8 MYOF HPS1 PEX5	1.47e-04	197	131	7	4998_DN
Drug	Equilin [474-86-2]; Up 200; 15uM; HL60; HT_HG-U133A	AKAP6 RELN SPTB INTS1 SI BORCS8 PRDM9	1.47e-04	197	131	7	3039_UP
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A	PDE3B BORCS8 MYOF HPS1 PRKAR1B ROBO1 ALDH4A1	1.47e-04	197	131	7	5314_UP
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	PDE3B NRF1 SLC7A8 RFTN1 IRS2 HERC3 ZNF324B	1.52e-04	198	131	7	5582_DN
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	PDE3B WWOX CALR BORCS8 HPS1 ALDH4A1 FH	1.52e-04	198	131	7	2626_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	NRF1 TTLL5 GPATCH3 HPS1 IRS2 HERC3 CTNNB1	1.52e-04	198	131	7	3854_DN
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A	KIF21B DPP4 RFTN1 NAV2 IRS2 CDH11 KDM4B	1.52e-04	198	131	7	4836_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ARHGAP4 MYOF HPS1 PEX5 PRKAR1B ZNF324 KDM4B	1.52e-04	198	131	7	3258_UP
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	KALRN TTLL5 MYOF MRC2 APOBEC2 ZNF324B KDM4B	1.57e-04	199	131	7	3546_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	PDE3B DVL3 ASAP1 BORCS8 MYOF PRKAR1B ZNF324	1.57e-04	199	131	7	5575_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NRF1 TTLL5 BORCS8 HPS1 PEX5 PRKAR1B HERC3	1.57e-04	199	131	7	5421_DN
Drug	Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A	DPP4 WWOX ZNF549 TTLL5 ZNF749 ALDH4A1 ADGRL3	1.62e-04	200	131	7	4076_DN
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	GALNT12 MYOF SLC46A3 HPS1 ZNF324 IRS2 KDM4B	1.62e-04	200	131	7	3840_UP
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SLC7A8 HPS1 NAV2 PEX5 PRKAR1B ZNF324 IRS2	1.62e-04	200	131	7	1692_UP
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	WWOX NRF1 MRC2 HPS1 PRKAR1B ALDH4A1 IRS2	1.62e-04	200	131	7	4542_DN
Drug	2,4,4'-trichlorobiphenyl	KIF21B GABRP ACER1 WWOX ANK1 FOXP2 KALRN MYO19 TTLL5 DVL3 MYLK2 PRDM9 CDH22 NALCN KCNG4 SCN1A SHCBP1 NAV2 MSS51 MPTX1	1.64e-04	1411	131	20	ctd:C081766
Disease	immature platelet measurement	MYO1G KALRN CARMIL1 ASAP1 PDIA5 ZNF324B	1.20e-05	119	125	6	EFO_0803541
Disease	FEV/FEC ratio	AKAP6 FNDC3B MGAM MYH9 TUT7 GALNT12 DNAL1 CHRNA5 ASAP1 FREM2 PLXDC2 MRC2 LRP1 NAV2 KCNS3 HSP90AB2P CSMD1	1.73e-05	1228	125	17	EFO_0004713
Disease	cortical thickness	AKAP6 ANKRD13B FLII DPP4 RELN WWOX FOXP2 GALNT12 PLXDC2 PIK3R1 LRP1 NAV2 ROBO1 KCNS3 CDH11 KDM4B	1.99e-05	1113	125	16	EFO_0004840
Disease	Migraine Disorders	GABRQ LRP1 ATP1A2	2.06e-05	13	125	3	C0149931
Disease	Familial or sporadic hemiplegic migraine	SCN1A ATP1A2	5.33e-05	3	125	2	cv:CN295307
Disease	Familial hemiplegic migraine	SCN1A ATP1A2	5.33e-05	3	125	2	cv:C0338484
Disease	congenital nystagmus (is_implicated_in)	MYO7A ROBO1	5.33e-05	3	125	2	DOID:9649 (is_implicated_in)
Disease	urate measurement, bone density	AKAP6 GABRP PDE3B WWOX CARMIL1 SLC7A8 PRKAR1B ROBO1 KCNS3 CAMKMT EPHB1	6.78e-05	619	125	11	EFO_0003923, EFO_0004531
Disease	epilepsy (implicated_via_orthology)	WWOX KALRN SCN1A MIB1 LRP1 ATP1A2	7.07e-05	163	125	6	DOID:1826 (implicated_via_orthology)
Disease	brain measurement, neuroimaging measurement	KIF21B DPP4 WWOX FOXP2 GALNT12 MYLK2 MIB1 NAV2 ROBO1 KCNS3	1.22e-04	550	125	10	EFO_0004346, EFO_0004464
Disease	hereditary spherocytosis (is_implicated_in)	ANK1 SPTB	1.77e-04	5	125	2	DOID:12971 (is_implicated_in)
Disease	Hereditary spherocytosis	ANK1 SPTB	1.77e-04	5	125	2	cv:C0037889
Disease	Anemia, hereditary spherocytic hemolytic	ANK1 SPTB	1.77e-04	5	125	2	C0221409
Disease	Cerebral Small Vessel Diseases	SCN1A ATP1A2	1.77e-04	5	125	2	C2733158
Disease	cleft lip	AKAP6 WWOX ICE1 KCNG4 KCNS3 CSMD1 MGAM2	2.15e-04	284	125	7	EFO_0003959
Disease	Autosomal dominant nonsyndromic hearing loss	MYH9 MYO7A GRHL2	2.50e-04	29	125	3	cv:C5779548
Disease	1,5 anhydroglucitol measurement	MGAM SI MGAM2	2.50e-04	29	125	3	EFO_0008009
Disease	age at diagnosis, substance-related disorder	FOXP2 BIRC6	2.64e-04	6	125	2	EFO_0004918, MONDO_0002494
Disease	interleukin 18 measurement	RELN TTC27 BIRC6 PIK3R1	3.11e-04	76	125	4	EFO_0004581
Disease	stomach cancer (is_marker_for)	CALR RGN CTNNB1 KDM4B EPHB1	3.55e-04	142	125	5	DOID:10534 (is_marker_for)
Disease	Autism Spectrum Disorders	RELN GABRQ SHANK3 SCN1A	4.77e-04	85	125	4	C1510586
Disease	oppositional defiant disorder measurement	GRHL2 PCDH20 MYLK2	4.78e-04	36	125	3	EFO_0007679
Disease	Hereditary spherocytosis	ANK1 SPTB	4.90e-04	8	125	2	C0037889
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	CPNE2 MAN2A1 BIRC6 PRDM9	5.44e-04	88	125	4	EFO_0803332
Disease	blood molybdenum measurement	AKAP6 XKR4 TMEM68	5.62e-04	38	125	3	EFO_0007582
Disease	lung cancer (is_marker_for)	CALR CTNNB1 KDM4B	6.07e-04	39	125	3	DOID:1324 (is_marker_for)
Disease	bilirubin measurement	ANK1 CARMIL1 SPTB TTC27 BIRC6 PLA2R1 DGAT2 EPHB1	6.08e-04	442	125	8	EFO_0004570
Disease	lung cancer (implicated_via_orthology)	XPC ROBO1	6.29e-04	9	125	2	DOID:1324 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	AKAP6 GABRP FNDC3B MYH9 WWOX ANK1 KALRN DVL3 DDIT3 PCDH20 ZNF644 ROBO1 CTNNB1	6.49e-04	1074	125	13	C0006142
Disease	Childhood Medulloblastoma	IRS2 CTNNB1 KDM4B	8.09e-04	43	125	3	C0278510
Disease	Proteinuria	DPP4 MYH9 CLCN5	8.09e-04	43	125	3	C0033687
Disease	Melanotic medulloblastoma	IRS2 CTNNB1 KDM4B	8.09e-04	43	125	3	C1275668
Disease	Medullomyoblastoma	IRS2 CTNNB1 KDM4B	8.09e-04	43	125	3	C0205833
Disease	Desmoplastic Medulloblastoma	IRS2 CTNNB1 KDM4B	8.09e-04	43	125	3	C0751291
Disease	Adult Medulloblastoma	IRS2 CTNNB1 KDM4B	8.09e-04	43	125	3	C0278876
Disease	esophagus squamous cell carcinoma (is_implicated_in)	WWOX CALR CHRNA5	9.25e-04	45	125	3	DOID:3748 (is_implicated_in)
Disease	Semantic-Pragmatic Disorder	FOXP2 SHANK3	9.55e-04	11	125	2	C0454655
Disease	cell growth regulator with EF hand domain protein 1 measurement	CPNE2 PLXDC2	9.55e-04	11	125	2	EFO_0801461
Disease	Auditory Processing Disorder, Central	FOXP2 SHANK3	9.55e-04	11	125	2	C0751257
Disease	Language Delay	FOXP2 SHANK3	9.55e-04	11	125	2	C0023012
Disease	Language Development Disorders	FOXP2 SHANK3	9.55e-04	11	125	2	C0023014
Disease	Speech Delay	FOXP2 SHANK3	9.55e-04	11	125	2	C0241210
Disease	Acute Promyelocytic Leukemia	FNDC3B ITGB2 PRKAR1A	9.86e-04	46	125	3	C0023487
Disease	immature platelet count	KALRN CARMIL1 ASAP1 PDIA5	1.09e-03	106	125	4	EFO_0803544
Disease	Medulloblastoma	IRS2 CTNNB1 KDM4B	1.26e-03	50	125	3	C0025149
Disease	immature platelet fraction	KALRN CARMIL1 ASAP1 PDIA5	1.43e-03	114	125	4	EFO_0009187
Disease	Drug habituation	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0013170
Disease	Drug abuse	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0013146
Disease	Prescription Drug Abuse	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C4316881
Disease	Substance-Related Disorders	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0236969
Disease	Drug Use Disorders	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0013222
Disease	Drug Dependence	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C1510472
Disease	Substance Dependence	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0038580
Disease	Substance Use Disorders	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	XKR4 CHRNA5 PLA2R1 CSMD1	1.48e-03	115	125	4	C0029231
Disease	Substance abuse problem	XKR4 CHRNA5 PLA2R1 CSMD1	1.52e-03	116	125	4	C0740858
Disease	Nephrosis	ITGB2 DDIT3	1.80e-03	15	125	2	C0027720
Disease	Muscular Atrophy	PRKAR1A CTNNB1	1.80e-03	15	125	2	C0026846
Disease	Neurogenic Muscular Atrophy	PRKAR1A CTNNB1	1.80e-03	15	125	2	C0270948
Disease	reaction time measurement	AKAP6 MYO1G DPP4 WWOX FOXP2 NAV2 CAMKMT HERC3 CSMD1	2.00e-03	658	125	9	EFO_0008393
Disease	puberty onset measurement	FNDC3B BIRC6 ZNF324 ZNF324B	2.00e-03	125	125	4	EFO_0005677
Disease	Insulin Resistance	PIK3R1 PRKAR1A IRS2	2.13e-03	60	125	3	C0021655
Disease	Insulin Sensitivity	PIK3R1 PRKAR1A IRS2	2.13e-03	60	125	3	C0920563
Disease	Abnormality of refraction	AKAP6 FNDC3B WWOX BIRC6 ASAP1 ROBO1 CAMKMT CTNNB1 ADGRL3	2.32e-03	673	125	9	HP_0000539
Disease	partial epilepsy	SCN1A ADGRL3	2.32e-03	17	125	2	EFO_0004263
Disease	lysophosphatidylcholine measurement	MGAM WWOX MIB1	2.34e-03	62	125	3	EFO_0010224
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	WWOX TTLL5 DDIT3 ASAP1	2.38e-03	131	125	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	WWOX TTLL5 DDIT3 ASAP1	2.38e-03	131	125	4	C4552091
Disease	Juvenile arthritis	WWOX TTLL5 DDIT3 ASAP1	2.38e-03	131	125	4	C3495559
Disease	Juvenile psoriatic arthritis	WWOX TTLL5 DDIT3 ASAP1	2.38e-03	131	125	4	C3714758
Disease	Juvenile-Onset Still Disease	WWOX TTLL5 DDIT3 ASAP1	2.65e-03	135	125	4	C0087031
Disease	chronic obstructive pulmonary disease	AKAP6 FNDC3B MYH9 WWOX GALNT12 CHRNA5 MRC2 KCNS3 HSP90AB2P	2.69e-03	688	125	9	EFO_0000341
Disease	metabolite measurement	WWOX ICE1 XKR4 MYOF HPS1 TMEM68 CSMD1 EPHB1	2.71e-03	560	125	8	EFO_0004725
Disease	neuroticism measurement, cognitive function measurement	DPP4 FOXP2 KALRN BIRC6 ZZZ3 NAV2 CSMD1 EPHB1	2.89e-03	566	125	8	EFO_0007660, EFO_0008354
Disease	severe acute respiratory syndrome, COVID-19	RELN WWOX MYO7A CLCN5 PLXDC2 CSMD1 ADGRL3	3.01e-03	447	125	7	EFO_0000694, MONDO_0100096
Disease	schizophrenia (implicated_via_orthology)	RELN SHANK3 CSMD1	3.04e-03	68	125	3	DOID:5419 (implicated_via_orthology)
Disease	Colorectal Carcinoma	AKAP6 KALRN CALR GALNT12 DDIT3 CDH22 ZZZ3 LRP1 CTNNB1	3.07e-03	702	125	9	C0009402
Disease	anorexia nervosa	AKAP6 WWOX ALDH4A1	3.30e-03	70	125	3	MONDO_0005351
Disease	creatinine measurement	KIF21B NRF1 TTC27 GRHL2 BIRC6 ZZZ3 PLXDC2 PIK3R1 KCNS3 FH RNF128	3.42e-03	995	125	11	EFO_0004518
Disease	Hereditary hearing loss and deafness	MYH9 MYO7A GRHL2 DGUOK	3.51e-03	146	125	4	cv:C0236038
Disease	lung cancer (is_implicated_in)	CALR DVL3 CHRNA5	3.86e-03	74	125	3	DOID:1324 (is_implicated_in)
Disease	Bronchiectasis	DNAL1 PIK3R1	3.89e-03	22	125	2	C0006267
Disease	mean platelet volume	LRRC66 MYH9 NRF1 COL6A6 KALRN CARMIL1 SHANK3 ASAP1 PDIA5 IRS2 ZNF324B	4.12e-03	1020	125	11	EFO_0004584
Disease	Nonsyndromic genetic hearing loss	MYH9 MYO7A GRHL2	4.17e-03	76	125	3	cv:C5680182

Protein segments in the cluster

Peptide	Gene	Start	Entry
AIWAVGQIIQDYDSD	CPNE2	341	Q96FN4
QFEWVTIEQSGELVY	BIRC6	4116	Q9NR09
ICITQDGWVDIYSDF	CATSPER4	256	Q7RTX7
LQTEAVNDYIAVWDG	CSMD1	2191	Q96PZ7
IDGQSIESGSIEYDW	CALR3	186	Q96L12
EVDWCESNFQYSELV	ACER1	11	Q8TDN7
LWYQDGRIVETDESQ	ADGRA3	276	Q8IWK6
QDWDADGSIVSYLQD	ANK1	1701	P16157
SYLQDAAQGSWQEEV	ANK1	1711	P16157
AVDENGLWVIYATEQ	ADGRL3	266	Q9HAR2
FENGSLSDIEWHIYQ	DGUOK	156	Q16854
CVVGDEEVWTSDVQY	ALDH4A1	66	P30038
DVVDWLYHNVEGFTD	DVL3	446	Q92997
FGDNIEDEWFIVYVI	ECD	81	O95905
YVWQNFVEQEEGESK	APOBEC2	186	Q9Y235
QFVSDVAWGELDYLV	NUBP2	116	Q9Y5Y2
EQWTVLEGVEVQTDY	RFTN1	376	Q14699
GGWNFLNYVTEELVD	SLC7A8	246	Q9UHI5
LLEAGSEYDQVTIWE	ANKRD13B	516	Q86YJ7
GWEEVSGYDENLNTI	EPHB1	41	P54762
QFYEVAVVAWNSEGF	PCDH20	501	Q8N6Y1
NNYLTDEGLDNETFW	PODN	271	Q7Z5L7
DVDTSQVLYEWEQGF	CTNNB1	56	P35222
PFESEDNQGIVYAWV	FLII	1091	Q13045
YESNEWDTEPLQVFV	MAN2A1	156	Q16706
EGQVFWDDGQSIDTY	MGAM2	1701	Q2M2H8
EGEEVYSWSESQDQV	INTS1	1136	Q8N201
LYHDFWEEQVETGQT	MSS51	331	Q4VC12
QEEYAVEGLEWSFIN	MYO19	451	Q96H55
YTVEDIILFWDDNGN	GABRQ	206	Q9UN88
WTRNTEDITQEEYGE	HSP90AB2P	211	Q58FF8
GNSNYNWEELEETAI	HERC3	936	Q15034
AIDWLTGNFYFVDDI	LRP1	286	Q07954
AGNIYWTDQGFDVIE	LRP1	1976	Q07954
TDINLFLGEAYTVEW	MGAM	1836	O43451
KEGAFYERTVTEWQQ	FREM2	631	Q5SZK8
TEWQQQDITEGRLFY	FREM2	641	Q5SZK8
LSFQEELAYWGIEEA	KCNG4	141	Q8TDN1
LVFYTDAQFWQEEEG	GPATCH3	336	Q96I76
YNGETLVFEESNWFI	PCYOX1	121	Q9UHG3
LNNVLSGNWYFDEET	MYLK2	491	Q9H1R3
WTEGIVNEFYEQGDE	PDE3B	951	Q13370
GDAVDVTQDYNETDW	PEX5	126	P50542
VTQDYNETDWSQEFI	PEX5	131	P50542
ENVKGAVWTVDEVEY	FOXP2	566	O15409
DFVFDLDTWQEQIYS	KIF21B	51	O75037
QALDWIQETGEFYLS	KALRN	1141	O60229
VNYSAVADGEVEQNW	NRF1	346	Q16656
DISGSLYDDDVAQWN	KDM4B	136	O94953
EGEYFWTALQDLNST	MRC2	576	Q9UBG0
NGITDWVYEEEVFSA	DPP4	196	P27487
VFSFCQEIEYWGINE	KCNS3	96	Q9BQ31
QEIEYWGINELFIDS	KCNS3	101	Q9BQ31
EYQREGIEWNFIDFG	MYH9	491	P35579
EWLGNENTEDQYSLV	PIK3R1	596	P27986
QVYEAFIQSGADEAW	DQX1	531	Q8TE96
NDILGEWTYETVAQE	LRRC66	531	Q68CR7
DLDTSWVDFVQFYIQ	RELN	1121	P78509
EEVVVVWDNGTAANY	MIB1	46	Q86YT6
TEDEEAANNGYSWLI	PRDM9	281	Q9NQV7
DDQYWAFSDIQTGRV	PRPF19	326	Q9UMS4
YFAVAAENEQEQEGW	IRS2	121	Q9Y4H2
DSEGCWVAYTLEQQD	ITGB2	666	P05107
WNTGYLFQVEFDDAT	CA5A	96	P35218
WTYDGSQVDIILEDQ	CHRNA5	191	P30532
EDSYGQEWTYEQRKV	ATP1A2	896	P50993
GEDLSDNTWEYIFAI	ICE1	2106	Q9Y2F5
NIEEIAYNAVSFTWD	GRHL2	346	Q6ISB3
AYNAVSFTWDVNEEA	GRHL2	351	Q6ISB3
AIELGYLTAEQFDEW	FH	486	P07954
ITDGNSEANQWEVAY	FNDC3B	611	Q53EP0
VGTYDDFNTIDWVRE	CLCN5	81	P51795
WEEQSQGAIYTVEYA	BORCS8	56	Q96FH0
EAYAEEFGNETWGVT	CALR	336	P27797
VWNQFFVIEEYTGPD	CDH11	56	P55287
VIDVIDWNTFEYLGN	GALNT12	256	Q8IXK2
FQAEDEQDYVAWISV	ASAP1	396	Q9ULH1
VIDQGETDVYVNNEW	PRKAR1A	176	P10644
VVDQGEVDVYVNGEW	PRKAR1B	176	P31321
WYEDLQEVLSSDENG	DDIT3	21	P35638
GFSYREEVQWDVDTI	CARMIL1	171	Q5VZK9
WNQFFVVEEYTGTEP	CDH22	66	Q9UJ99
VGDTLEELWISYNFI	DNAL1	91	Q4LDG9
VATEGAEVLFYWTDQ	HPS1	6	Q92902
GSDEAQRFLQEWEVY	SDHAF3	46	Q9NRP4
ETAAEESWDYVQFQL	CD37	136	P11049
GAVQYADSWDLEFEI	COL6A6	476	A6NMZ7
ENEVYKQVIFEEGSW	DGAT2	281	Q96PD7
LQLESWGYDGNDVEF	GABRP	176	O00591
DTWAYIAAEGDQEVL	MPHOSPH8	501	Q99549
QYDNYGSTAEDIVEW	PDIA5	241	Q14554
QDLIQWGADYFEALS	ROPN1B	31	Q9BZX4
SVENGFDTQIYTDWA	NAV2	81	Q8IVL1
WNEGSYELLIQEESS	SLC46A3	441	Q7Z3Q1
VRYFDNGTALVVQWD	PLXDC2	216	Q6UX71
TVWELSEEGVYGQDS	RNF128	61	Q8TEB7
FDENQSFVGVIWDVF	MPTX1	81	A8MV57
SIFHQEVQYDGLWID	SI	491	P14410
YFDQVDISNGLDWSL	RGN	146	Q15493
QELWVVFDDSGVFDQ	SHCBP1	176	Q8NEM2
VLVEKYEWSQEEAAG	SRPK1	611	Q96SB4
FWIALQDQNDTGEYT	PLA2R1	576	Q13018
GDKEEQEVSWTQYTQ	ARHGAP4	471	P98171
NETVFEFDWKSYIQD	SCN1A	306	P35498
QDNYEAIWEKIEGFV	AKAP6	771	Q13023
TEEEVGAWVQYTSIF	CAMKMT	81	Q7Z624
VFFTQEEWDYLDPAQ	ZNF189	21	O75820
VAVYFSQEEWGLLDT	ZNF324	6	O75467
DIAVYFSQEEWGLLD	ZNF549	31	Q6P9A3
EDVAIYFSQEEWGIL	ZNF749	11	O43361
TLVDEGDLYNWEVAI	CDC34	31	P49427
TADFIEQSVFYWEQV	TRIM13	361	O60858
EEWFGVEQLEDYLNF	TMEM68	26	Q96MH6
ALQYLESVDVEGVAW	SHANK3	606	Q9BYB0
VTFEDVAVYFTQNEW	ZNF620	11	Q6ZNG0
VYFADVGTDVWLAVD	XKR4	121	Q5GH76
YGWEQETDENGQVFF	WWOX	61	Q9NZC7
EEVTLVVYDIWEQGD	REM2	161	Q8IYK8
SGEATWSAYIEVQEF	ROBO1	531	Q9Y6N7
AEAWIGEQELYVISD	SPTB	1596	P11277
WDNVELGDYTTQAIE	ZNF644	861	Q9H582
FEDVAIYFSEQEWQD	ZNF786	11	Q8N393
WPQESVTFEDVAVYF	ZNF621	6	Q6ZSS3
EDVAIYFSQEEWGLL	ZNF416	31	Q9BWM5
FEDVAVTFTQEEWGQ	ZNF543	11	Q08ER8
VQAFDIWLNSTEYGE	TMEM129	221	A0AVI4
EENDLGLFGYWQTEE	XPC	726	Q01831
DSFQENEDGYRWQDT	TUT7	131	Q5VYS8
VDGWNIYFFDQIDEL	TUT7	1206	Q5VYS8
IWENYILTSTDVGEF	TTC27	631	Q6P3X3
EALYEEAVSQWFTPD	SMYD5	226	Q6GMV2
VWDQYTHSLGNFERE	ZZZ3	566	Q8IYH5
FAWEGEVENNVYSQA	TTLL5	1116	Q6EMB2
ASSQQEIFENGEAYW	ZNF311	151	Q5JNZ3
VAVYFSQEEWGLLDT	ZNF324B	6	Q6AW86
FTVYEAASQEGWVFL	NALCN	271	Q8IZF0
EQEEYEREGITWQSV	MYO1G	431	B0I1T2
EREGITWQSVEYFNN	MYO1G	436	B0I1T2
VAVNWTGVYFVDEQE	MYO7A	1491	Q13402
WDQTIIFDEVEIYGE	MYOF	1186	Q9NZM1